TargED Biopharmaceuticals
8 known investors
TargED Biopharmaceuticals is a Netherlands-based biotechnology company developing first-in-class biological drugs that use small antibodies (VHH) to deliver enzymes to sites of thrombosis for targeted thrombolysis. Its lead compound, TGD001, is a targeted thrombolytic in preclinical development for thrombotic disorders including immune thrombotic thrombocytopenic purpura (iTTP) and acute ischemic stroke.